These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9820479)

  • 21. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].
    Stanic AK; Shashidharamurthy R; Bezbradica JS; Matsuki N; Yoshimura Y; Miyake S; Choi EY; Schell TD; Van Kaer L; Tevethia SS; Roopenian DC; Yamamura T; Joyce S
    J Immunol; 2003 Nov; 171(9):4539-51. PubMed ID: 14568927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapeutic potential for ceramide-based activators of iNKT cells.
    Berkers CR; Ovaa H
    Trends Pharmacol Sci; 2005 May; 26(5):252-7. PubMed ID: 15860372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
    Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Motoki K; Ueno H; Nakagawa R; Sato H; Kondo E; Koseki H; Taniguchi M
    Science; 1997 Nov; 278(5343):1626-9. PubMed ID: 9374463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
    Brossay L; Chioda M; Burdin N; Koezuka Y; Casorati G; Dellabona P; Kronenberg M
    J Exp Med; 1998 Oct; 188(8):1521-8. PubMed ID: 9782129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
    Gumperz JE
    Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
    J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells.
    Roark JH; Park SH; Jayawardena J; Kavita U; Shannon M; Bendelac A
    J Immunol; 1998 Apr; 160(7):3121-7. PubMed ID: 9531266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
    Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
    J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1.
    Huang MM; Borszcz P; Sidobre S; Kronenberg M; Kane KP
    J Immunol; 2004 May; 172(9):5304-12. PubMed ID: 15100269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
    Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
    Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
    J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.
    Sidobre S; Naidenko OV; Sim BC; Gascoigne NR; Garcia KC; Kronenberg M
    J Immunol; 2002 Aug; 169(3):1340-8. PubMed ID: 12133957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
    van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
    Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycolipid targets of CD1-mediated T-cell responses.
    Moody DB; Besra GS
    Immunology; 2001 Nov; 104(3):243-51. PubMed ID: 11722638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.